BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Moodys
Citi
UBS
Mallinckrodt
Cerilliant
Express Scripts
Boehringer Ingelheim
Accenture
Farmers Insurance

Generated: January 16, 2018

DrugPatentWatch Database Preview

BETAPACE AF Drug Profile

« Back to Dashboard

When do Betapace Af patents expire, and what generic alternatives are available?

Betapace Af is a drug marketed by Covis Pharma Bv and is included in one NDA.

The generic ingredient in BETAPACE AF is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.
Drug patent expirations by year for BETAPACE AF
Pharmacology for BETAPACE AF
Drug ClassAntiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration
Medical Subject Heading (MeSH) Categories for BETAPACE AF

US Patents and Regulatory Information for BETAPACE AF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis Pharma Bv BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-006 Apr 2, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Covis Pharma Bv BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-005 Mar 14, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Covis Pharma Bv BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-007 Apr 2, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Covis Pharma Bv BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-001 Feb 22, 2000 AB2 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Covis Pharma Bv BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-003 Feb 22, 2000 AB2 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Covis Pharma Bv BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-002 Feb 22, 2000 AB2 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Queensland Health
Cipla
AstraZeneca
US Department of Justice
Novartis
Colorcon
Merck
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot